Nevertheless, our study showed that targeting NOX4-generated ROS and disrupting the self-sustaining cycle between NOX4, ROS, and NLRP3 inflammasomes could effectively inhibit the occurrence and progression of pulmonary fibrosis. The gene discussed is NLRP3; the disease is pulmonary fibrosis.